News

 

Accenture to expand healthcare capabilities in Germany with acquisition of consus.health

Tech consultancy firm Accenture is going to expand its healthcare capabilities in Germany with the acquisition of leading German healthcare management consultancy, consus.health. The details of the acquisition, which is expected to complete subject to customary closing conditions, were not disclosed. Freiburg im Breisgau-based consus.health was founded in 2012 and has more than 600 healthcare […]
August 29, 2024

Global medtech company Getinge to acquire organ transport products and services company, Paragonix Technologies

Sweden-based global medtech company, Getinge, is going to acquire 100% of US-based organ transport products and services company, Paragonix Technologies for approximately $477 million. The $477 million consists of the upfront purchase price and currently forecast additional earn-out payments between 2024 and 2026. The payment for all issued and outstanding shares will be made on […]
August 29, 2024

Mubadala and CBC Group acquire Belgian biopharma UCB’s China operations

UCB, a Belgian biopharma company, plans to divest its business in China, to CBC Group, a Singapore-based investment firm, and Mubadala, a global investment company from Abu Dhabi, for $680 million.  The deal, pending regulatory approval, is expected to close in Q4 2024 and includes UCB’s neurology and allergy portfolios, as well as its manufacturing site in Zhuhai, China.
August 29, 2024

UK launches £400 million public-private partnership to address critical need in pharmaceutical testing

The UK’s Department of Health and Social Care (DHSC), NHS England, and the Association of the British Pharmaceutical Industry (ABPI) have launched a £400 million initiative to improve the country’s pharmaceutical testing capabilities. Termed the ‘Voluntary Scheme for Branded Medicine Pricing, Access and Growth’ (VPAG), this public-private investment will create up to 18 new clinical trial hubs across the UK, speeding up the development and availability of new medicines, as detailed in the August 28 press release.
August 29, 2024

PAI Partners seeks sovereign wealth fund boost for Sanofi consumer healthcare bid

PAI Partners, the French private equity firm, is in talks with two of the world's largest sovereign wealth funds to support its offer for Sanofi SA's consumer health division. According to anonymous Bloomberg sources, the Abu Dhabi Investment Authority (ADIA) and Singapore's GIC Pte are considering joining PAI's consortium. The deal could value the business […]
August 29, 2024

Hillhouse and EQT vie to acquire global BPO provider GeBBS

The sale of US-based healthcare BPO firm GeBBS Healthcare Solutions has entered its final stage, with Asian and European funds competing for acquisition. Hong Kong’s Hillhouse Investment has emerged as the frontrunner and is reported to have offered approximately USD $870 million for a 100% stake, slightly ahead of Sweden’s EQT Partners' bid of $855-860 […]
August 29, 2024

NY-based PE firm Warburg Pincus exits India’s pharmacy chain MedPlus

Warburg Pincus, a global private equity firm based in New York, exited Indian pharmacy chain MedPlus Health Services on August 26, selling its entire 11.4% stake for approximately $100 million through an open market transaction. The sale was carried out by its Mauritius-based unit, Lavender Rose Investment Ltd.
August 29, 2024

Final two companies selected for billion-dollar Canberra hospital tender

The Australian Capital Territory (ACT) Government has announced the final shortlist of two property development companies for its new hospital project tender. Spain's Grupo ACS, through its Australian subsidiary Cimic and its construction arm CPB Contractors, has secured a place on the shortlist and will compete against London-based and Australia-founded firm Multiplex Construction.
With an investment […]
August 27, 2024
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us